萬豐奧威(002085.SZ):子公司獲得恆大新能源汽車鎂合金部件項目
格隆匯12月9日丨萬豐奧威(002085.SZ)公佈,公司收到子公司萬豐鎂瑞丁控股有限公司(“萬豐鎂瑞丁”)的通知,萬豐鎂瑞丁近日獲得恆大恆馳新能源汽車研究院(上海)有限公司(“恆大新能源汽車”)EM3項目2款儀表盤支架定點函,項目訂單金額約4200萬元。
以上項目的合作是對公司輕量化產品質量的充分肯定和深度認可,為公司進一步開拓新能源汽車領域奠定了堅實的基礎,公司後續將持續與恆大新能源汽車開展新產品配套,不斷提升配套份額。該訂單對公司銷售收入預計不會產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.